Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HST vs GSK✓SelectedUSD · GSKHST vs GSK performance historyLatest closeAs of+0.86%11/16
Stock and ETF performance explorer

HST vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+89.1%
GSK return
+46.9%
Excess return
+42.2%
Maximum drawdown
-36.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.9%-0.1%+0.9%+0.9%
7D+1.7%-1.3%+3.1%+2.0%
30D+7.3%+2.7%+4.6%+6.7%
3M+13.3%+2.7%+10.6%+12.6%
6M+26.0%+3.3%+22.7%+24.9%
YTD+53.6%+6.5%+47.1%+50.8%
1Y+57.8%+10.7%+47.2%+53.8%
3Y+81.6%+64.4%+17.2%+56.8%
5Y+89.1%+46.7%+42.4%+49.8%
All+89.1%+46.9%+42.2%+49.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling